• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LEMAITRE VASCULAR, INC SYNTEL SILICONE OVER-THE-WIRE EMBOLECTOMY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LEMAITRE VASCULAR, INC SYNTEL SILICONE OVER-THE-WIRE EMBOLECTOMY CATHETER Back to Search Results
Catalog Number A4E04
Medical Device Problem Code Material Rupture (1546)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/11/2026
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that during a vaivt procedure, the balloon ruptured upon inflation at the target lesion.The device was replaced with another catheter of the same size, and the procedure was completed successfully.No issues were noted during device preparation, and only mild calcification was present.No patient injury was reported.
 
Additional Manufacturer Narrative
The device was discarded and unavailable for investigation.Therefore, we could not conclusively determine the root cause of the reported incident.Balloon rupture is an inherent risk associated with this type of device, and given the nature of the product and the procedures in which it is used, this event is considered a known complication.Procedural factors or anatomical features, such as calcification or plaque, may have contributed to the reported issue.The instructions for use (ifu) include the following warning regarding possible complications: in common with other catheterization procedures, complications may occur.These may include but are not limited to: infection, local hematomas, intimal disruption, arterial dissection, perforation and rupture, hemorrhage, arterial thrombosis, distal emboli of blood clots or arteriosclerotic plaque, air embolus, aneurysms, arterial spasms, arteriovenous fistula formation, balloon rupture or tip separation with fragmentation and distal embolization.Exercise caution when encountering extremely diseased vessels.Arterial rupture or balloon failure due to sharp calcified plaque may occur.The possibility of balloon rupture must be taken into account when considering the risks involved in the catheterization procedure.The production and traceability record for the device was reviewed; no issues were found during manufacturing or packaging that would cause or contribute to the reported event.All quality control tests were completed successfully and met specification.We have not received any other complaints of a similar nature for devices from this lot.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNTEL SILICONE OVER-THE-WIRE EMBOLECTOMY CATHETER
Common Device Name
EMBOLECTOMY CATHETER
Manufacturer (Section D)
LEMAITRE VASCULAR, INC
63 second ave
burlington MA 01803
Manufacturer (Section G)
LEMAITRE VASCULAR, INC
63 second ave
burlington MA 01803
Manufacturer Contact
peter song
63 second ave
burlington, MA 01803
7814251683
MDR Report Key24828990
Report Number1220948-2026-00078
Device Sequence Number9187136
Product Code DXE
UDI-Device Identifier00840663109890
UDI-Public(01)00840663109890(11)250425(17)300328(10)PYT00001398(91)A4E04
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K202049
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 04/09/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberA4E04
Device Lot NumberPYT00001398
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/11/2026
Initial Report FDA Received Date04/09/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured04/25/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-